G

GI Innovation Inc
KOSDAQ:358570

Watchlist Manager
GI Innovation Inc
KOSDAQ:358570
Watchlist
Price: 10 030 KRW -4.11% Market Closed
Market Cap: 443.5B KRW
Have any thoughts about
GI Innovation Inc?
Write Note

GI Innovation Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GI Innovation Inc
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
G
GI Innovation Inc
KOSDAQ:358570
Cash from Financing Activities
â‚©25.1B
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Cash from Financing Activities
-â‚©273.9B
CAGR 3-Years
N/A
CAGR 5-Years
-8%
CAGR 10-Years
-18%
SK Bioscience Co Ltd
KRX:302440
Cash from Financing Activities
-â‚©89.6B
CAGR 3-Years
-288%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Cash from Financing Activities
-â‚©181.7B
CAGR 3-Years
-91%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Cash from Financing Activities
-â‚©17.7B
CAGR 3-Years
N/A
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Cash from Financing Activities
â‚©33.2B
CAGR 3-Years
-42%
CAGR 5-Years
39%
CAGR 10-Years
N/A
No Stocks Found

GI Innovation Inc
Glance View

Market Cap
443.3B KRW
Industry
Biotechnology

GI Innovation, Inc. engages in the development of biopharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 88 full-time employees. The company went IPO on 2023-03-30. The firm is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.

Intrinsic Value
9 325.56 KRW
Overvaluation 7%
Intrinsic Value
Price
G

See Also

What is GI Innovation Inc's Cash from Financing Activities?
Cash from Financing Activities
25.1B KRW

Based on the financial report for Dec 31, 2023, GI Innovation Inc's Cash from Financing Activities amounts to 25.1B KRW.

What is GI Innovation Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-7%

The average annual Cash from Financing Activities growth rates for GI Innovation Inc have been -7% over the past three years .

Back to Top